Prediction of Microvascular Invasion of Hepatocellular Carcinoma: Preoperative CT and Histopathologic Correlation

Size: px
Start display at page:

Download "Prediction of Microvascular Invasion of Hepatocellular Carcinoma: Preoperative CT and Histopathologic Correlation"

Transcription

1 Gastrointestinal Imaging Original Research Gastrointestinal Imaging Original Research Chen-Te Chou 1,2 Ran-Chou Chen 2,3 Wei-Chan Lin 2,4 Chih-Jan Ko 5 Chia-Bang Chen 1 Yao-Li Chen 5,6 Chou CT, Chen RC, Lin WC, Ko CJ, Chen CB, Chen YL Keywords: CT, hepatocellular carcinoma, microvascular invasion, tumor capsule, tumor margin DOI: /AJR Received January 17, 2013; accepted after revision October 30, R. C. Chen and Y. L. Chen contributed equally to this study. The work was supported by a research grant from the National Science Council (grant B MY2). 1 Department of Radiology, Chang-Hua Christian Hospital, Changhua City, Taiwan. 2 Department of Biomedical Imaging and Radiological Science, National Yang-Ming Medical University, Taipei, Taiwan. 3 Department of Radiology, Taipei City Hospital, Taipei City, Taiwan. 4 Department of Radiology, Cathay General Hospital, Taipei, Taiwan. 5 Transplant Medicine & Surgery Research Centre, Chang-Hua Christian Hospital, No. 135 Nanhsiao St, 500 Chang-Hua, Taiwan. Address correspondence to Y. L. Chen (chouchente@yahoo.com.tw). 6 School of Medicine, Chung Shan Medical University, Taichung City, Taiwan. WEB This is a web exclusive article. AJR 2014; 203:W253 W X/14/2033 W253 American Roentgen Ray Society Prediction of Microvascular Invasion of Hepatocellular Carcinoma: Preoperative CT and Histopathologic Correlation OBJECTIVE. The objective of our study was to prospectively investigate whether nonsmooth margins detected on multiphasic CT images correlate with the presence and location of microvascular invasion (MVI) in hepatocellular carcinoma (HCC). SUBJECTS AND METHODS. A total of 102 patients with preoperative CT findings of solitary HCC were prospectively enrolled. size, tumor capsule, tumor margins, and peritumoral enhancement on preoperative CT images were assessed. Histopathologic results including the following were also recorded: tumor differentiation; liver fibrosis score; presence or absence of MVI; and, if present, the location of MVI. Correlation between tumor margin on preoperative CT images and histopathologic location of MVI was determined. RESULTS. Pathologic examination revealed MVI in 60 of the 102 HCC specimens. Although the results of the univariate analysis showed that tumor size, higher Edmondson- Steiner grade, and nonsmooth tumor margins were associated with MVI, multivariate analysis revealed that only nonsmooth margins correlated with the presence of MVI in HCC (p < 0.001). Of the 60 HCC specimens with histopathologic evidence of MVI, 40 exhibited focal nonsmooth margins. In addition, the locations of the nonsmooth margins and MVI were similar in 36 of the 40 specimens. CONCLUSION. Nonsmooth tumor margins correlated with the histopathologic presence and location of MVI. Therefore, nonsmooth margins detected on multiphasic CT may be predictive of MVI in HCC. H istopathologic evidence of vascular tumor invasion is a wellknown prognostic factor for patients who have undergone hepatic resection or liver transplant for the treatment of hepatocellular carcinoma (HCC) [1 4]. Macrovascular invasion, which is easily diagnosed using routine cross-sectional imaging, is a relative contraindication for surgery and transplant. Pathologic markers suggestive of an increased risk of microvascular invasion (MVI) include large tumor size, multiple tumors, intrahepatic micrometastasis, poor histologic grade, and gross anatomic subtype as defined by the Liver Cancer Study Group of Japan [5]. The three subtypes are defined as follows: a simple nodular type (a distinctly nodular tumor that frequently has a capsule); a simple nodular type with extranodular growth (a single nodular tumor with varying degrees of tumor growth beyond the tumor capsule); and a confluent multinodular type (a confluence of several minute to small nodules) [6 10]. Iwatsuki et al. [11] reported that the risk of recurrence of HCC after liver transplant was 4.4-fold higher in patients with MVI and 15- fold higher in patients with macrovascular invasion. Therefore, preoperative diagnosis of HCC with MVI is essential to help predict the outcome of patients who undergo liver transplant or curative liver resection. Recent studies have shown that PET [12] and diffusion-weighted MRI [13] can be used to predict the presence of MVI. Several studies [8, 14 16], including a retrospective study by our group [14], have shown that there is a certain degree of correlation between the contours of the tumors seen on CT or MRI and the Japanese Gross Classification System [5]. However, none of those studies was able to show a direct correlation between nonsmooth tumor margins and histopathologic evidence of MVI. In this prospective study, we investigated whether nonsmooth margins detected on multiphasic CT correlate with the presence and location of MVI in HCC. W253

2 Subjects and Methods Patients This prospective study was approved by the institutional review board of our institute, and informed consent was obtained from all of the study participants. The inclusion criteria for patients were as follows: chronic liver disease with dynamic CT evidence of a solitary hepatic tumor showing hypervascular enhancement in the arterial phase and contrast washout in the equilibrium phase, no history of malignancy, and agreement to undergo surgical resection or liver transplant for histopathologic diagnosis. During the period from January 2011 through March 2012, a total of 105 patients with radiographic evidence of HCC underwent elective curative hepatectomy or liver transplant in our institution. Of these 105 patients, partial hepatectomy was performed in 71 patients, 11 of whom underwent hepatectomy without resection of the adjacent major vessels because of impaired liver function; anatomic hemihepatectomy was performed in 27 patients; and liver transplant was performed in seven patients. Three patients were excluded from the study because of a diagnosis of hepatocholangiocarcinoma (two patients) or macrovascular portal venous thrombus (one patient). Therefore, the final study population comprised 102 patients (73 men and 29 women) with a mean age of 62.6 years (range, years). Underlying hepatic disease included hepatitis B in 42 patients, hepatitis C in 43 patients, combined hepatitis B and C in three patients, alcoholic liver disease in five patients, and cryptogenic liver disease in nine patients. According to the Child-Pugh liver disease classification, 91 patients had Child-Pugh class A disease, eight had Child-Pugh class B disease, and three had Child- Pugh class C disease. CT Image Acquisition CT images of the liver were obtained with a 16- MDCT scanner (LightSpeed Ultra 16, GE Healthcare) using the following parameters: z-axis modulation; a gantry rotation time of 0.6 second for the unenhanced studies and for the hepatic arterial and portovenous phases (beam pitch, 0.825:1) and a gantry rotation time of 0.8 second for the equilibrium phase (beam pitch, 1.1:1); 5-mm section thickness reconstructions; 120 kvp; ma; and a standard reconstruction algorithm. Patients were scanned in a craniocaudal direction. Nonionic contrast medium (iohexol [Omnipaque 350, GE Healthcare]) was administered at a total dose of ml with an injection rate of 3 ml/s through a 20-gauge venous cannula placed in the antecubital vein. For triphasic acquisitions, scanning was started with a 10-second scanning delay ( seconds after injection of the contrast Fig. 1 Illustration shows three patterns of tumor margins. (Drawing by Chou CT) Smooth margin agent) for the hepatic arterial phase after the attenuation value of the aorta reached 120 HU. Fifteen seconds after the endpoint of the hepatic arterial phase ( seconds after injection of the contrast agent), scans for the portovenous phase were acquired. Equilibrium phase images were acquired 120 seconds ( seconds after injection of the contrast agent) after the end of the acquisition of the portovenous phase. Whole-liver scanning was completed in 4 8 seconds while the patients held their breath. Coronary and sagittal images were reconstructed with a 5-mm slice thickness using raw imaging data for equilibrium phase CT and a standard reconstruction algorithm. Imaging Analysis The imaging analysis was performed on a dual-screen diagnostic workstation. Before starting the study, two experienced radiologists who were blinded to clinical information independently reviewed the preoperative CT images for each patient. Coronary and sagittal reformatted equilibrium phase images of the whole liver, which supplemented transverse plane images, were provided to the two reviewers. margins on equilibrium phase images were grouped into one of the three following categories depending on margin characteristics (Fig. 1): smooth margin, presenting as a smooth tumor normal liver interface seen on all axial, coronary, and sagittal images; nonsmooth margin, presenting as focal outgrowth of nodules protruding into the nontumor parenchyma (Fig. 2); or nonsmooth margin with multinodular type (Fig. 3), presenting as multifocal outgrowths protruding into the nontumoral parenchyma [14, 17]. For each tumor with nonsmooth margins, the reviewers recorded the location of nonsmooth margins on the liver map (location on transverse, coronary, and sagittal planes) for correlation with histopathologic findings. The presence or absence of tumor capsules was assessed in the equilibrium phase by identifying a thin, linear, enhanced structure encasing the tumor. s were then categorized into one of the Nonsmooth margins Single nodular type Focal extranodular type Multinodular type three following groups according to the presence or absence of tumor capsules: tumors presenting with capsules that completely surrounded the tumor circumference, tumors presenting with capsules that did not completely surround the tumor circumference, or tumors without radiologic evidence of a tumor capsule. The presence or absence of peritumoral enhancement was assessed in the dynamic CT study. Peritumoral enhancement was defined as the existence of a detectable arterial-enhancing area adjacent to the tumor border on arterial phase images that became isodense compared with the liver parenchyma on equilibrium phase images. Differences between the two reviewers were resolved by a third radiologist who joined a consensus conference and who was also blind to clinical information. Lesion Tracking In patients who underwent hepatectomy or liver transplant, consistency between CT and pathologic findings was reached by means of a lesion-tracking procedure. For each assessment, an investigator who did not participate in the initial review of the images selected the largest tumor diameter in the axial, coronal, and sagittal planes to prepare the liver maps (one map for each plane). Each liver map was completed by drawing each individual liver lesion and adjacent major vascular and anatomic landmarks around the tumor on a respective map according to the preoperative CT images and the Couinaud system of liver anatomy. The maps were drawn as accurately as possible for CT and pathologic findings. In each assessment, a continuous number was allocated to each lesion. In patients who underwent partial hepatectomy, the surgeon matched the location of the margin on the axial plane of a specimen with that of the markers so that a radiologic-pathologic correlation could be determined (Fig. 1C). The two satellite nodules in two patients with multinodular type HCC were excluded. W254

3 C Fig year-old man with solitary hepatocellular carcinoma (HCC) at segment VI of liver who underwent curative hepatectomy. A, Arterial phase CT image shows nodular tumor (arrow) with heterogeneous enhancement at segment VI of liver. B, shows extranodular extension (arrowhead) on late phase CT image. C, Surgeon indicated axial plane with sutures (three or four sutures) at border of specimen (arrow) to enable radiologic-pathologic correlation. D, Photomicrograph (H and E stain, 40) of histopathologic specimen reveals microvascular invasion of tumor (arrow). Histopathologic Examination All hepatic specimens were sliced in 5-mm increments by the pathologist. The plane of the section was chosen to be as close to the axial plane as possible on the basis of the markers provided by the surgeon and the major vascular and anatomic landmarks. The entire tumor margin in each specimen slice was divided into multiple sequential tissue blocks, coded with slice and sequential tissue block numbers, and submitted for microscopic examination. The pathologist recorded the slice and sequential tissue block numbers on the corresponding spatial positions of the tumor. All hepatic specimens were reviewed by a hepatic pathologist with more than 20 years of experience in hepatic pathology who was blinded to A the preoperative CT findings and clinical information. The histopathologic features of the tumors, fibrosis score, and location of MVI in tumor specimens were recorded. The degree of tumor differentiation was categorized according to the Edmondson-Steiner classification [18]. The degree of liver fibrosis was categorized according to the Metavir fibrosis scoring system [19]. In the HCC specimens with MVI, the pathologist marked the MVI site on the liver maps for each tumor. Correlation of Pathologic Specimens With Imaging Findings Radiologic-pathologic correlation was determined to evaluate the relationship between nonsmooth tumor margins and histopathologic evidence of MVI (Fig. 4). During the histopathologic examination, the octants of the tumors presenting with MVI were identified using the liver maps completed by the pathologist. During examination of the CT images, the octants of the tumors showing nonsmooth margins were identified using the liver maps completed by the radiologists. A radiologic-pathologic correlation was defined as specimens that showed the presence of MVI and a nonsmooth margin in the same octant. Statistical Analysis The interobserver difference between the initial two observers was evaluated with the kappa test. An independent Student t test was used to compare tumor size between the MVI-positive and D B W255

4 MVI-negative groups. Categoric variables, such as fibrosing score, Edmondson-Steiner grade of tumor, peritumoral enhancement, tumor margin, and radiologic evidence of tumor capsule, were analyzed by the chi-square test or Fisher exact test. The parameters found to have statistical significance by univariate analyses were entered into a stepwise, multiple logistic regression model to elucidate the independent predictors of MVI. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for the parameters that showed statistical significance by multivariate analysis. A p value < 0.05 was considered to indicate a statistically significant difference. TABLE 1: Clinical Characteristics of 102 Patients With Solitary Hepatocellular Carcinoma (HCC) Clinical Risk Factors All Patients (n = 102) Histopathologic MVI Negative (n = 42) Positive (n = 60) Age (y) Mean ± SD 62.6 ± ± ± 11.5 Sex (no. of patients) Male Female size (cm) < Mean ± SD 4.4 ± ± ± 4.3 Underlying liver disease (no. of patients) HBV HCV HBV and HCV Alcoholic liver disease Other Child-Pugh class (no. of patients) A B C AFP Mean ± SD (ng/ml) 1837 ± ± ± 11, < 20 ng/ml (no. of patients) ng/ml (no. of patients) Histologic grade a (no. of patients) I II III Liver fibrosis score b (no. of patients) Note MVI = microvascular invasion, HBV = hepatitis B virus, HCV = hepatitis C virus, AFP = α-fetoprotein. a According to Edmondson-Steiner classification [18]. b Metavir score [19]. Results Of the 102 specimens, 45 were determined to be focal extranodular type, nine were multinodular type, and the other 48 were single nodular type. Interobserver agreement was good between the two reviewers of the radiologic images. The kappa values were for tumor margin, for peritumoral enhancement, and for radiologic evidence of tumor capsule. Histopathologic analysis of the specimens revealed that 60 of the HCC lesions were positive for MVI. The results of the univariate analysis for the clinical characteristics and histopathologic findings in patients with and in those without MVI are shown in Table 1. size (MVI-positive group vs MVI-negative group: mean ± SD, 5.6 ± 4.3 cm vs 2.7 ± 1.7 cm, respectively; p < 0.001) and higher Edmondson-Steiner grade (grade III vs grades I and II; p = 0.020) were associated with the presence of MVI. There were no significant differences between the two patient groups in age, sex, liver fibrosis score, underlying liver disease, Child-Pugh class, or a-fetoprotein level. Univariate analyses of the radiologic findings of patients with and those without MVI are shown in Table 2. Histopathologic examination of the 45 focal extranodular HCC specimens revealed that 40 showed evidence of MVI. In addition, all nine of the multinodular HCC specimens showed MVI. Histopathologic examination revealed that five specimens with focal extranodular HCC showed no evidence of MVI and that 11 of 48 HCC specimens with smooth margins showed evidence of MVI. Of the 60 HCC specimens with histopathologic evidence of MVI, 40 showed evidence of focal extranodular extension, nine showed evidence of multinodular extension, and 11 had smooth margins. In 36 of 40 HCC specimens with focal extranodular extension, nonsmooth margins on CT images were located in the same octant as MVI in histopathologic specimens. The locations of MVI and nonsmooth margins were in different octants in the other four (4/40) HCC specimens. Of the nine HCC specimens showing multinodular extension, the location of MVI and that of nonsmooth margins was considered a mismatch. In the 49 HCC specimens with nonsmooth margins and MVI, the pathologic MVI octants were the same as the CT nonsmooth octants in 73% (36/49) of the cases. The presence of tumor capsules on CT images (p = 0.003) and the presence of nonsmooth tumor margins on preoperative CT images (p < 0.001) were associated with the presence of MVI. Of the 52 tumors with radiologic evidence of capsules, CT showed incomplete patterns for 30 tu- p W256

5 mors and complete patterns for 22 tumors. There was no significant difference in the presence of MVI between the tumors with CT findings showing an incomplete capsule and those with CT findings showing a complete capsule. Seven HCCs showed wedge peritumoral enhancement, one HCC showed circumferential enhancement, and the other HCCs showed no obvious peritumoral enhancement. Peritumoral enhancement revealed no statistically significant associations with MVI. The results of the multivariate logistic regression analysis of risk factors in patients with and those without MVI are shown in Table 3. Only nonsmooth tumor margin was associated with MVI (p < 0.001). The presence of nonsmooth tumor margins had a sensitivity of 81.7% (95% CI, %), a specificity of 88.1% (95% CI, %), an accuracy rate of 84.3% (95% CI, %), a PPV of 90.7% (95% CI, %), and an NPV of 77.1% (95% CI, %) in predicting MVI. TABLE 2: Univariate Analysis of Radiologic Findings for Patients With and Patients Without Microvascular Invasion (MVI) Radiologic Risk Factors Total No. of Patients Discussion In this study, we prospectively explored the correlation between nonsmooth tumor margins identified on dynamic four-phase CT with the presence of MVI in histopathologic specimens. Of the 54 HCCs with nonsmooth margins, 49 had MVI. The site of MVI in the pathologic specimens correlated with the site of focal extranodular extension on CT images in 73% (36/49) of the cases. In four specimens, MVI was seen along the smooth margin instead of the focal nonsmooth margin. Of the 48 HCC specimens with smooth margins, 11 showed evidence of MVI. Nonsmooth tumor margins as a predictor of MVI had a sensitivity of 81.7% and a specificity of 88.1%. Our results confirm that nonsmooth tumor margins identified on multiphasic CT can predict MVI and that MVI most frequently takes place at the site of extranodular extension. Kanai et al. [20] have proposed a gross classification system in which nodular HCC can be subclassified into a single nodular Histopathologic MVI Negative (n = 42 Patients) Positive (n = 60 Patients) Radiologic evidence of tumor capsule Negative Positive Incomplete capsule Complete capsule Peritumoral enhancement a Negative Positive margin < Smooth Nonsmooth Focal extranodular Multinodular a Fisher exact test. type, a single nodular type with extranodular growth, and a contiguous multinodular type. Studies have shown that the single nodular type with extranodular growth and the contiguous multinodular type are associated with increased risk of MVI, micrometastasis, and poorer outcome [7, 8, 18, 20, 21]. Preoperative prediction of growth subtype with imaging had been attempted in the past, but the imaging technique (10-mm slice thickness) was not sensitive enough [8]. In our study, we found that nonsmooth tumor p Fig year-old woman with solitary hepatocellular carcinoma (HCC) at segments V and VI of liver who underwent hepatectomy. A, Arterial phase CT image shows nodular tumor (arrows) with heterogeneous enhancement at segments V and VI of liver. B, shows multinodular extension (arrows) on equilibrium phase CT image. A B W257

6 4 Preoperative CT study Axial * Imaging investigator Extranodular extension Extranodular extension Axial Sagittal 1 * Coronal * Extranodular extension 2 Liver map TABLE 3: Multivariate Logistic Regression Analysis of Risk Factors in Patients With and Patients Without Microvascular Invasion Risk Factor Odds Ratio 95% Confidence Limits Lower Upper size Histologic grade Radiologic evidence of tumor capsule margin < Sagittal Axial Coronal Pathologist investigator MVI MVI Sagittal Coronal MVI Octant 1 Octant Match or not margins identified on dynamic CT (5-mm slice thickness) could predict the presence of MVI. A retrospective study by our group also showed that nonsmooth tumor margins on CT were predictive of MVI [14]. Highquality CT images to identify the tumor contour changes might be needed in the prediction of MVI. However, among the 60 HCC specimens with evidence of MVI, the location of MVI was found on the smooth border in 11 specimens with complete smooth margins and four specimens with focal extranodular extensions. Thus, the possibility of MVI occurring on a smooth tumor margin should be kept in mind. Chandarana et al. [22] reported that tumor multifocality was the only variable that was significantly correlated with the presence of MVI in explants. No other clinical, pathologic, or imaging features were useful in significantly predicting MVI [22]. The differences in findings between their study and our study might be because of different study designs, lower imaging resolution for their study (matrix, ), and smaller tumor size in their study cohort. Small tumor size might make the tumor contour harder to assess. Recent studies with gadoxetic acid showed that evidence of nonsmooth tumor margins in the hepatobiliary phase MRI was an indicator of MVI [15, 16]. An analysis of tumor margins in the hepatobiliary phase of gadoxetic acid enhanced MR images, therefore, seems to be useful in the preoperative prediction of MVI. In the current study, the univariate analyses revealed that larger tumor size, the presence of tumor capsules, and nonsmooth tumor margins on preoperative CT studies were associated with the presence of MVI; however, the multivariate analysis showed that only nonsmooth tumor margin was associated with MVI. On the basis of our re- Surgical specimen Slice 4, no. 2 Slice 1 Slice 2 Slice 3 Slice 4 Slice 5 Slice 6 Pathologist cut specimen along axial plane in 5-mm-thick increments according to markers made by surgeon and vascular anatomy Each slice was coded with a slice number Surgical specimen: slice 4 tissue block Slice 4, no. 1 Slice 4, no. 3 Slice 4, no. 4 Entire tumor margin on each slice was divided into multiple sequential blocks Each tissue block was coded with a slice number and a sequential tissue block number Histopathologic examination p 8 6 Radiologic 8 6 Pathologic MVI site of tumor was located according to slice number and sequential tissue block number Fig. 4 Flowchart shows steps in radiologic-pathologic correlation. MVI = microvascular invasion. (Drawing by Chou CT) W258

7 sults, we recommend that radiologists review tients who underwent anatomic hepatectomy operative prediction of the microvascular invasion and communicate any significant findings relating only are needed. of hepatocellular carcinoma with diffusion-weighted to tumor margins on preoperative CT reports and inform the surgeon of the possibility of MVI. Patients with HCC that has nonsmooth tumor margins may require more aggressive treatment, such as more extensive surgery with or without adjuvant therapy. Peritumoral enhancement has been shown to be suggestive of an increased risk of microvascular tumor invasion when seen on MR images [16] and on combined CT hepatic angiographic and CT arterioportographic images [23]. In our study, peritumoral enhancement on CT was not a significant risk factor for MVI. This discrepancy in findings might be due to differences among the different imaging modalities. Further studies of the relationship between peritumoral enhancement and MVI on dynamic CT images are needed. Adachi et al. [24] reported that blood vessels of the fibrous capsule were frequently invaded by cancer cells and stated that the presence of a fibrous capsule was a predictor of portal venous invasion. Witjes et al. [25] also reported that MVI was significantly associated with the presence of a capsule on dynamic contrast-enhanced MR images. Our results were similar to those in the studies by Adachi et al. and Witjes et al., in which radiologic evidence of a capsule correlated with MVI. However, Ariizumi et al. [15] reported that an incomplete capsule was likely to be associated with MVI. In other studies, the presence of fibrous capsules in HCC has been shown to be a favorable prognostic factor because the capsule may prevent invasion of HCC into the adjacent liver parenchyma [25, 26]. The relationship between the presence or absence of tumor capsules and MVI remains controversial [27]. This study has two limitations. First, the underlying liver disease in the majority (88/102) of patients in the study was viral hepatitis. When HCC develops in patients with chronic liver disease with underlying alcoholic complications, HCC may have a different clinical course. Thus, further studies are required to investigate MVI characteristics when HCC develops in patients with alcoholic liver disease. Second, 11 patients underwent hepatectomy without resection of the adjacent major vessels because of impaired liver function. With no major vascular landmarks as reference points, specimens from these patients might have caused some bias in the radiologic-pathologic correlation. However, the surgeon placed the referent markers to indicate the CT axial plane as accurately as possible. We believe this strategy might have minimized the bias. Future studies on the radiologic-pathologic correlation of MVI in pa- In conclusion, evidence of nonsmooth tumor margins on preoperative CT images is a predictor of MVI. The characteristics of tumor margins on preoperative CT scans should be considered when developing a treatment strategy for patients with HCC. References 1. Shah SA, Cleary SP, Wei AC, et al. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 2007; 141: Ikai I, Arii S, Kojiro M, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 2004; 101: Lauwers GY, Terris B, Balis UJ, et al. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol 2002; 26: Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001; 233: Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer, 2nd English ed. Tokyo, Japan: Kanehara, Shirabe K, Aishima S, Taketomi A, et al. Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation. Br J Surg 2011; 98: Eguchi S, Takatsuki M, Hidaka M, et al. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J Surg 2010; 34: Hui AM, Takayama T, Sano K, et al. Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol 2000; 33: Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008; 15: Gouw AS, Balabaud C, Kusano H, Todo S, Ichida T, Kojiro M. Markers for microvascular invasion in hepatocellular carcinoma: where do we stand? Liver Transpl 2011; 17(suppl 2):S72 S Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000; 191: Kornberg A, Freesmeyer M, Bärthel E, et al. 18 F- FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients. Am J Transplant 2009; 9: [Erratum in Am J Transplant 2009; 9:1255] 13. Suh YJ, Kim MJ, Choi JY, Park MS, Kim KW. Pre- imaging. Liver Transpl 2012; 18: Chou CT, Chen RC, Lee CW, Ko CJ, Wu HK, Chen YL. Prediction of microvascular invasion of hepatocellular carcinoma by pre-operative CT imaging. Br J Radiol 2012; 85: Ariizumi S, Kitagawa K, Kotera Y, et al. A nonsmooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2011; 18: Kim H, Park MS, Choi JY, et al. Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur Radiol 2009; 19: Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, Kojiro M. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 2003; 26: Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7: Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C: the META- VIR Cooperative Study Group. Hepatology 1996; 24: Kanai T, Hirohashi S, Upton MP, et al. Pathology of small hepatocellular carcinoma: a proposal for a new gross classification. Cancer 1987; 60: Nagano Y, Shimada H, Takeda K, et al. Predictive factors of microvascular invasion in patients with hepatocellular carcinoma larger than 5 cm. World J Surg 2008; 32: Chandarana H, Robinson E, Hajdu CH, Drozhinin L, Babb JS, Taouli B. Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? AJR 2011; 196: Nishie A, Yoshimitsu K, Asayama Y, et al. Radiologic detectability of minute portal venous invasion in hepatocellular carcinoma. AJR 2008; 190: Adachi E, Maeda T, Kajiyama K, et al. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer 1996; 77: Witjes CD, Willemssen FE, Verheij J, et al. Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI. J Magn Reson Imaging 2012; 36: Ng IO, Lai EC, Ng MM, Fan ST. encapsulation in hepatocellular carcinoma: a pathologic study of 189 cases. Cancer 1992; 70: Torimura T, Ueno T, Inuzuka S, Tanaka M, Abe H, Tanikawa K. Mechanism of fibrous capsule formation surrounding hepatocellular carcinoma: immunohistochemical study. Arch Pathol Lab Med 1991; 115: W259

Int J Clin Exp Med 2017;10(8): /ISSN: /IJCEM

Int J Clin Exp Med 2017;10(8): /ISSN: /IJCEM Int J Clin Exp Med 2017;10(8):11728-11738 www.ijcem.com /ISSN:1940-5901/IJCEM0054237 Original Article Predict microvascular invasion in hepatocellular carcinoma by dynamic contrast-enhanced magnetic resonance

More information

Liver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital.

Liver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital. New Frontiers in Dynamic Volume Imaging dynamic volume CT Case Study Brochure Chang Gung Memorial Hospital http://www.toshibamedicalsystems.com Toshiba Medical Systems Corporation 2010-2011. All rights

More information

Imaging in gastric cancer

Imaging in gastric cancer Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.

More information

Microvascular Invasion in Hepatocellular Carcinoma: Is It Predictable With Pretransplant MRI?

Microvascular Invasion in Hepatocellular Carcinoma: Is It Predictable With Pretransplant MRI? Gastrointestinal Imaging Original Research Chandarana et al. Pretransplant MRI of Hepatocellular Carcinoma Gastrointestinal Imaging Original Research Hersh Chandarana 1 Emma Robinson 1 Cristina H. Hajdu

More information

Innovations in HCC Imaging: MDCT/MRI

Innovations in HCC Imaging: MDCT/MRI Innovations in HCC Imaging: MDCT/MRI Anthony E. Cheng, M.D. Cardinal MRI Center Cardinal Santos Medical Center, Wilson Street, San Juan Innovations in HCC Imaging: Goals/Objectives MDCT/MRI Learn the diagnostic

More information

MRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm

MRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm Gastrointestinal Imaging Original Research Choi et al. MRI of Small HCC Gastrointestinal Imaging Original Research Moon Hyung Choi 1 Joon-Il Choi 1 Young Joon Lee 1 Michael Yong Park 1 Sung Eun Rha 1 Chandana

More information

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly LIVER IMAGING TIPS IN VARIOUS MODALITIES M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly Hepatocellular carcinoma is a common malignancy for which prevention, screening, diagnosis,

More information

Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece

Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece Hepatospecificcontrast agents Gadobenate dimeglumine (Multihance) Gadoxeticacid (Primovist) 3-5% liver uptake 50% liver uptake Hepatobiliary

More information

Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging

Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging Ronnie T.P. Poon, MBBS, MS, PhD Chair Professor of Hepatobiliary and Pancreatic Surgery Chief of Hepatobiliary and Pancreatic Surgery

More information

Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis

Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis GE Healthcare Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis CT clinical case study lesion characterization Desiree Morgan, MD Vice Chair of Clinical Research Professor

More information

Detection and Characterization of Hepatocellular Carcinoma by Imaging

Detection and Characterization of Hepatocellular Carcinoma by Imaging CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:S136 S140 Detection and Characterization of Hepatocellular Carcinoma by Imaging OSAMU MATSUI Department of Imaging Diagnosis and Interventional Radiology,

More information

Effect of hepatitis B virus DNA replication level and anti-hbv therapy on microvascular invasion of hepatocellular carcinoma

Effect of hepatitis B virus DNA replication level and anti-hbv therapy on microvascular invasion of hepatocellular carcinoma Qu et al. Infectious Agents and Cancer (2019) 14:2 https://doi.org/10.1186/s13027-019-0219-8 RESEARCH ARTICLE Open Access Effect of hepatitis B virus DNA replication level and anti-hbv therapy on microvascular

More information

Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1

Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1 Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1 Jae-Hoon Lim, M.D., Jin Woong Kim, M.D., Suk Hee Heo, M.D., Yong Yeon Jeong, M.D., Heoung Keun Kang, M.D. A 53-year-old

More information

Index terms: Liver, CT Liver neoplasm, CT. Korean J Radiol 2005;6: Received February 21, 2005; accepted after revision May 24, 2005.

Index terms: Liver, CT Liver neoplasm, CT. Korean J Radiol 2005;6: Received February 21, 2005; accepted after revision May 24, 2005. Depiction of Viable Tumor in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Multiphasic Helical CT with Review of the Previous Serial CT Images Kyung Mi Jang, MD 1 Dongil Choi,

More information

Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation

Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation Huang et al. BMC Cancer (2019) 19:364 https://doi.org/10.1186/s12885-019-5574-8 RESEARCH ARTICLE Open Access Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance

More information

Liver imaging takes a step forward with Ingenia

Liver imaging takes a step forward with Ingenia Publication for the Philips MRI Community ISSUE 49 2013 / 2 Liver imaging takes a step forward with Ingenia Lyon South Hospital strives to move from several studies first CT, then MR or PET to using just

More information

HCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP.

HCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? Arun J Sanyal M.B.B.S., M.D. Charles Caravati Professor of Medicine Virginia Commonwealth University Imaging features used

More information

HEPATOCYTE SPECIFIC CONTRAST MEDIA: WHERE DO WE STAND?

HEPATOCYTE SPECIFIC CONTRAST MEDIA: WHERE DO WE STAND? HEPATOCYTE SPECIFIC CONTRAST MEDIA: WHERE DO WE STAND? Andrew T. Trout, MD @AndrewTroutMD Disclosures No relevant disclosures Outline Review of hepatocyte specific contrast media Review of hepatocellular

More information

CT & MRI of Benign Liver Neoplasms Srinivasa R Prasad

CT & MRI of Benign Liver Neoplasms Srinivasa R Prasad CT & MRI of Benign Liver Neoplasms Srinivasa R Prasad No financial disclosures Acknowledgements Many thanks to Drs. Heiken, Narra & Menias (MIR) Dr. Sahani (MGH) for sharing images Benign Liver Tumors:

More information

Hepatocellular carcinoma (HCC) is a malignant liver neoplasm

Hepatocellular carcinoma (HCC) is a malignant liver neoplasm Diagn Interv Radiol 2011; 17:328 333 Turkish Society of Radiology 2011 ABDOMINAL IMAGING ORIGINAL ARTICLE Correlation of dynamic multidetector CT findings with pathological grades of hepatocellular carcinoma

More information

Histologic Characteristics of Hepatocellular Carcinomas Showing Atypical Enhancement Patterns on 4-Phase MDCT Examination

Histologic Characteristics of Hepatocellular Carcinomas Showing Atypical Enhancement Patterns on 4-Phase MDCT Examination Original Article http://dx.doi.org/10.3348/kjr.2012.13.5.586 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2012;13(5):586-593 Histologic Characteristics of Hepatocellular Carcinomas Showing Atypical

More information

Hepatocellular carcinoma (HCC) is the sixth most common type of cancer and ranks

Hepatocellular carcinoma (HCC) is the sixth most common type of cancer and ranks Diagn Interv Radiol 2018; 24:121 127 Turkish Society of Radiology 2018 ABDOMINAL IMAGING ORIGINAL ARTICLE A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B

More information

Focus on Dysplastic Nodules and Early Hepatocellular Carcinoma: An Eastern Point of View. Masamichi Kojiro

Focus on Dysplastic Nodules and Early Hepatocellular Carcinoma: An Eastern Point of View. Masamichi Kojiro Focus on Dysplastic Nodules and Early Hepatocellular Carcinoma: An Eastern Point of View Masamichi Kojiro Although increasing numbers of equivocal nodular lesions have been detected in patients with liver

More information

Differentiating small arterial only enhancing hepatocellular carcinoma from nontumorous arteroportal shunt with an emphasis on the precontrast phase

Differentiating small arterial only enhancing hepatocellular carcinoma from nontumorous arteroportal shunt with an emphasis on the precontrast phase Differentiating small arterial only enhancing hepatocellular carcinoma from nontumorous arteroportal shunt with an emphasis on the precontrast phase Poster No.: C-0739 Congress: ECR 2015 Type: Scientific

More information

Liver resection for HCC

Liver resection for HCC 8 th LIVER INTEREST GROUP Annual Meeting Cape Town 2017 Liver resection for HCC Jose Ramos University of the Witwatersrand Donald Gordon Medical Centre The liver is almost unique in that treatment of the

More information

Embolotherapy for Cholangiocarcinoma: 2016 Update

Embolotherapy for Cholangiocarcinoma: 2016 Update Embolotherapy for Cholangiocarcinoma: 2016 Update Igor Lobko,MD Chief, Division Vascular and Interventional Radiology Long Island Jewish Medical Center GEST 2016 Igor Lobko, M.D. No relevant financial

More information

INTRODUCTION. Yun Ku Cho 1, Ju Won Kim 1, Mi Young Kim 1, and Hyeon Je Cho 2

INTRODUCTION. Yun Ku Cho 1, Ju Won Kim 1, Mi Young Kim 1, and Hyeon Je Cho 2 Gut and Liver, Vol. 12,. 1, January 2018, pp. 79-85 ORiginal Article n-hypervascular Hypointense dules on Hepatocyte Phase Gadoxetic Acid-Enhanced MR Images: Transformation of MR Hepatobiliary Hypointense

More information

Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography

Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2013;11:187 192 Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography YOUNG JOO JIN,*

More information

MRI for HCC surveillance and reporting: LI-RADS. Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA

MRI for HCC surveillance and reporting: LI-RADS. Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA MRI for HCC surveillance and reporting: LI-RADS Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA Cirrhotic Nodules Regenerative Nodule Atypical Nodule Hyperplastic Nodule Dysplastic

More information

Prognostic factors after hepatic resection for the single hepatocellular carcinoma larger than 5 cm

Prognostic factors after hepatic resection for the single hepatocellular carcinoma larger than 5 cm ORIGINAL ARTICLE pissn 2288-6575 eissn 2288-6796 http://dx.doi.org/1174/astr.216.91.3.14 Annals of Surgical Treatment and Research Prognostic factors after hepatic resection for the single hepatocellular

More information

Management of Rare Liver Tumours

Management of Rare Liver Tumours Gian Luca Grazi Hepato-Biliary-Pancreatic Surgery National Cancer Institute Regina Elena Rome Fibrolamellar Carcinoma Mixed Hepato Cholangiocellular Carcinoma Hepatoblastoma Carcinosarcoma Primary Hepatic

More information

Primary Hepatic Undifferentiated Pleomorphic Sarcoma: CT and angiographic findings in two cases

Primary Hepatic Undifferentiated Pleomorphic Sarcoma: CT and angiographic findings in two cases J Radiol Sci 2013; 38: 15-19 Primary Hepatic Undifferentiated Pleomorphic Sarcoma: CT and angiographic findings in two cases Jan-Wen Ku Ying-Chi Tseng Kuo-Luon Kung Hsien-Chang Shen Yen-Lin Huang Chi-Jen

More information

doi: /hepr Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)

doi: /hepr Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version) bs_bs_banner Hepatology Research 2016; 46: 3 9 doi: 10.1111/hepr.12542 Special Report Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version) Masatoshi Kudo, Kazuomi Ueshima,

More information

Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary)

Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary) Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary) Staff Reviewers: Dr. Yoo Joung Ko (Medical Oncologist, Sunnybrook Odette Cancer

More information

Comparison of multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and cholangiocarcinoma

Comparison of multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and cholangiocarcinoma Comparison of multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and cholangiocarcinoma Poster No.: C-0245 Congress: ECR 2014 Type: Scientific Exhibit Authors: M. Yata,

More information

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department

More information

Natural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry

Natural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry 2015;112:872 876 Natural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry PETER L. JERNIGAN, MD, KOFFI WIMA, MS, DENNIS J. HANSEMAN, PhD, RICHARD

More information

Alice Fung, MD Oregon Health and Science University

Alice Fung, MD Oregon Health and Science University Alice Fung, MD Oregon Health and Science University Disclosure Comments The speaker Alice Fung, MD Has relevant financial relationships to disclose. Received honorarium from (Guerbet). This individual

More information

Anatomical and Functional MRI of the Pancreas

Anatomical and Functional MRI of the Pancreas Anatomical and Functional MRI of the Pancreas MA Bali, MD, T Metens, PhD Erasme Hospital Free University of Brussels Belgium mbali@ulb.ac.be Introduction The use of MRI to investigate the pancreas has

More information

How to apply HCC prediction models to practice?

How to apply HCC prediction models to practice? How to apply HCC prediction models to practice? Department of Internal Medicine, Keimyung University School of Medicine Woo Jin Chung HCC prediction models 독특하게간세포암환자들의생존은암의진행상태뿐아니라기저간기능의중증정도에영향을받는특성이있다.

More information

Surgical management of HCC. Evangelos Prassas Hepatobiliary and Pancreatic Surgery / Liver Transplantation Kings College Hospital / London

Surgical management of HCC. Evangelos Prassas Hepatobiliary and Pancreatic Surgery / Liver Transplantation Kings College Hospital / London Surgical management of HCC Evangelos Prassas Hepatobiliary and Pancreatic Surgery / Liver Transplantation Kings College Hospital / London Global distribution of HCC and staging systems WEST 1. Italy (Milan,

More information

Hepatic resection is a well-accepted therapy for hepatocellular

Hepatic resection is a well-accepted therapy for hepatocellular ORIGINAL ARTICLES Early and Late After Liver Resection for Hepatocellular Carcinoma Prognostic and Therapeutic Implications Nazario Portolani, MD,* Arianna Coniglio, MD,* Sara Ghidoni, MD,* Mara Giovanelli,

More information

Radiological Reasoning: Incidentally Discovered Liver Mass

Radiological Reasoning: Incidentally Discovered Liver Mass AJR Integrative Imaging LIFELONG LEARNING FOR RADIOLOGY This Radiological Reasoning article is available for SAM credit and CME credits when completed with the additional educational material provided

More information

EASL-EORTC Guidelines

EASL-EORTC Guidelines Pamplona, junio de 2008 CLINICAL PRACTICE GUIDELINES: PARADIGMS IN MANAGEMENT OF HCC EASL-EORTC Guidelines Bruno Sangro Clínica Universidad de Navarra. CIBERehd. Pamplona, Spain Levels of Evidence according

More information

Malignant Focal Liver Lesions

Malignant Focal Liver Lesions Malignant Focal Liver Lesions Other Than HCC Pablo R. Ros, MD, MPH, PhD Departments of Radiology and Pathology University Hospitals Cleveland Medical Center Case Western Reserve University Pablo.Ros@UHhospitals.org

More information

Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma

Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma Du et al. BMC Cancer 2014, 14:38 RESEARCH ARTICLE Open Access Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma Min Du 1, Lingli Chen 1, Jing Zhao 1, Feng

More information

Nonfunctioning Islet Cell Tumors of the Pancreas: Computed Tomography Findings

Nonfunctioning Islet Cell Tumors of the Pancreas: Computed Tomography Findings Chin J Radiol 2002; 27: 239-243 239 Nonfunctioning Islet Cell Tumors of the Pancreas: Computed Tomography Findings CHAO-HSUAN YEN 1 JEN-HWEY CHIANG 1 JEN-I HUANG 3 CHENG-SHI SU 2 YI-YOU CHIOU 1 CHENG-YEN

More information

The Egyptian Journal of Hospital Medicine (April 2018) Vol. 71(1), Page

The Egyptian Journal of Hospital Medicine (April 2018) Vol. 71(1), Page The Egyptian Journal of Hospital Medicine (April 2018) Vol. 71(1), Page 2315-2321 Role of MRI in Assessment of Hepatocellular Carcinoma (HCC) after TACE (Trans-arterial Chemoembolization) with Persistent

More information

Pathological Analysis of Small Hepatocellular Carcinoma with Poor Prognosis

Pathological Analysis of Small Hepatocellular Carcinoma with Poor Prognosis Pathological Analysis of Small Hepatocellular Carcinoma with Poor Prognosis Haeryoung Kim, M.D., Ph.D. Department of Pathology Seoul National University Bundang Hospital Small HCC Definition: HCC < 2cm

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 143 Effective Health Care Program Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma Executive Background and Objectives Hepatocellular carcinoma

More information

Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time

Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time MOLECULAR AND CLINICAL ONCOLOGY 1: 977-981, 2013 Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time NAOKI SHINGAKI, HIDEYUKI TAMAI, YOSHIYUKI MORI, KOSAKU MORIBATA,

More information

Imaging of Neuroendocrine Metastases

Imaging of Neuroendocrine Metastases Imaging of Neuroendocrine Metastases Aoife Kilcoyne, Shaunagh McDermott, Colin McCarthy,Manuel Patino, Dushyant Sahani, Michael Blake Abdominal Imaging Division Massachusetts General Hospital Disclosure

More information

Invited Re vie W. Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver diseases

Invited Re vie W. Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver diseases Histol Histopathol (1 998) 13: 1077-1 087 http://www.ehu.es/histoi-histopathol Histology and Histopathology Invited Re vie W Analytical histopathological diagnosis of small hepatocellular nodules in chronic

More information

Improvement of Image Quality with ß-Blocker Premedication on ECG-Gated 16-MDCT Coronary Angiography

Improvement of Image Quality with ß-Blocker Premedication on ECG-Gated 16-MDCT Coronary Angiography 16-MDCT Coronary Angiography Shim et al. 16-MDCT Coronary Angiography Sung Shine Shim 1 Yookyung Kim Soo Mee Lim Received December 1, 2003; accepted after revision June 1, 2004. 1 All authors: Department

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/19768 holds various files of this Leiden University dissertation. Author: Langevelde, Kirsten van Title: Are pulmonary embolism and deep-vein thrombosis

More information

Role of positron emission tomography/computed tomography in living donor liver transplantation for hepatocellular carcinoma

Role of positron emission tomography/computed tomography in living donor liver transplantation for hepatocellular carcinoma Review Article on Liver Transplantation for Hepatocellular Carcinoma Role of positron emission tomography/computed tomography in living donor liver transplantation for hepatocellular carcinoma Seung Duk

More information

Gastrointestinal Imaging Original Research

Gastrointestinal Imaging Original Research Gastrointestinal Imaging Original Research Jang et al. Multiphase CT in HCC Gastrointestinal Imaging Original Research Hyun-Jung Jang 1 Tae Kyoung Kim 1 Korosh Khalili 1 Leyla Yazdi 1 Ravi Menezes 1 Seong

More information

State of the Art Imaging for Hepatic Malignancy: My Assignment

State of the Art Imaging for Hepatic Malignancy: My Assignment State of the Art Imaging for Hepatic Malignancy: My Assignment CT vs MR vs MRCP Which one to choose for HCC vs Cholangiocarcinoma What special protocols to use for liver tumors Role of PET and Duplex US

More information

8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy.

8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy. U. Joseph Schoepf, MD Prof. (h.c.), FAHA, FSCBT-MR, FNASCI, FSCCT Professor of Radiology, Medicine, and Pediatrics Director, Division of Cardiovascular Imaging Consultant for / research support from: Astellas

More information

INTRALUMINAL GAS IN NON-PERFORATED ACUTE APPENDICITIS: A predictor of gangrenous appendicitis

INTRALUMINAL GAS IN NON-PERFORATED ACUTE APPENDICITIS: A predictor of gangrenous appendicitis INTRALUMINAL GAS IN NON-PERFORATED ACUTE APPENDICITIS: A predictor of gangrenous appendicitis DM Plata Ariza, MD; E Martínez Chamorro, MD; D Castaño Pardo, MD; M Arroyo López, MD; E Peghini Gavilanes,

More information

Microvascular Invasion in Hepatocellular Carcinoma and Liver Transplant

Microvascular Invasion in Hepatocellular Carcinoma and Liver Transplant Microvascular Invasion in Hepatocellular Carcinoma and Liver Transplant Neha Jakhete, 1 Behnam Saberi, 1 Naudia L. Jonassaint, 2 Arif M. Cosar, 1 Harry Luu, 1 Amy Kim, 1 Robert A. Anders, 3 Benjamin Philosophe,

More information

Imaging Decisions Start Here SM

Imaging Decisions Start Here SM Owing to its high resolution and wide anatomic coverage, dynamic first-pass perfusion 320-detector-row CT outperforms PET/CT for distinguishing benign from malignant lung nodules, researchers from Japan

More information

Hepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center

Hepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center Hepatocellular Carcinoma: A major global health problem David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center Hepatocellular Carcinoma WORLDWIDE The #2 Cancer Killer Overall cancer

More information

Compute-aided Differentiation of Focal Liver Disease in MR Imaging

Compute-aided Differentiation of Focal Liver Disease in MR Imaging 1063 Compute-aided Differentiation of Focal Liver Disease in MR Imaging Xuejun Zhang a, Masayuki Kanematsu b, Hiroshi Fujita c, Takeshi Hara c, Hiroshi Kondo b, Xiangrong Zhou c, Wenguang Li a and Hiroaki

More information

Hepatocellular Carcinoma: Diagnosis and Management

Hepatocellular Carcinoma: Diagnosis and Management Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm

More information

Outcomes in the NLST. Health system infrastructure needs to implement screening

Outcomes in the NLST. Health system infrastructure needs to implement screening Outcomes in the NLST Health system infrastructure needs to implement screening Denise R. Aberle, MD Professor of Radiology and Bioengineering David Geffen School of Medicine at UCLA 1 Disclosures I have

More information

Common and unusual CT and MRI manifestations of pancreatic adenocarcinoma: a pictorial review

Common and unusual CT and MRI manifestations of pancreatic adenocarcinoma: a pictorial review Review Article Common and unusual CT and MRI manifestations of pancreatic adenocarcinoma: a pictorial review Min-Jie Yang, Su Li, Yong-Guang Liu, Na Jiao, Jing-Shan Gong Department of Radiology, Shenzhen

More information

Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiographyassisted CT) with special reference to multi-step hepatocarcinogenesis

Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiographyassisted CT) with special reference to multi-step hepatocarcinogenesis Abdominal Imaging ª The Author(s) 2011. This article is published with open access at Springerlink.com Published online: 26 January 2011 Abdom Imaging (2011) 36:264 272 DOI: 10.1007/s00261-011-9685-1 INVITED

More information

NHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE LIVER ADVISORY GROUP UPDATE ON THE HCC DOWN-STAGING SERVICE EVALUATION

NHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE LIVER ADVISORY GROUP UPDATE ON THE HCC DOWN-STAGING SERVICE EVALUATION NHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE LIVER ADVISORY GROUP UPDATE ON THE HCC DOWN-STAGING SERVICE EVALUATION 1. A service development evaluation to transplant down-staged

More information

Small Pulmonary Nodules: Our Preliminary Experience in Volumetric Analysis of Doubling Times

Small Pulmonary Nodules: Our Preliminary Experience in Volumetric Analysis of Doubling Times Small Pulmonary Nodules: Our Preliminary Experience in Volumetric Analysis of Doubling Times Andrea Borghesi, MD Davide Farina, MD Roberto Maroldi, MD Department of Radiology University of Brescia Brescia,

More information

Management of hepatocellular carcinoma should consider both tumor factors and background liver factors

Management of hepatocellular carcinoma should consider both tumor factors and background liver factors Hepatocellular Carcinoma Column: Editorial Management of hepatocellular carcinoma should consider both tumor factors and background liver factors Shuji Nomoto, Mitsuhiro Hishida, Yoshikuni Inokawa, Hiroyuki

More information

Financial Disclosure

Financial Disclosure Benign Liver Masses Adil Abdalla, MBBS Creighton University-CHI Health August 25, 2018 Financial Disclosure Nothing to disclose Financial Disclosure 1 Objectives To assess patients with benign liver tumors

More information

Management of HepatoCellular Carcinoma

Management of HepatoCellular Carcinoma 9th Symposium GIC St Louis - 2010 Management of HepatoCellular Carcinoma Overview Pierre A. Clavien, MD, PhD Department of Surgery University Hospital Zurich Zurich, Switzerland Hepatocellular carcinoma

More information

Multiphasic MDCT Enhancement Pattern of Hepatocellular Carcinoma Smaller Than 3 cm in Diameter: Tumor Size and Cellular Differentiation

Multiphasic MDCT Enhancement Pattern of Hepatocellular Carcinoma Smaller Than 3 cm in Diameter: Tumor Size and Cellular Differentiation Gastrointestinal Imaging Original Research Yoon et al. MDCT of Hepatocellular Carcinoma Gastrointestinal Imaging Original Research Soon Ho Yoon 1 Jeong Min Lee 1,2 Young Ho So 1 Sung Hyun Hong 3 Soo Jin

More information

Staging Colorectal Cancer

Staging Colorectal Cancer Staging Colorectal Cancer CT is recommended as the initial staging scan for colorectal cancer to assess local extent of the disease and to look for metastases to the liver and/or lung Further imaging for

More information

MRI IN THE CHARACTERIZATION OF SEMINOMATOUS AND NONSEMINOMATOUS GERM CELL TUMORS OF THE TESTIS

MRI IN THE CHARACTERIZATION OF SEMINOMATOUS AND NONSEMINOMATOUS GERM CELL TUMORS OF THE TESTIS MRI IN THE CHARACTERIZATION OF SEMINOMATOUS AND NONSEMINOMATOUS GERM CELL TUMORS OF THE TESTIS Ambesh Deshar *, Gyanendra KC and Zhang Lopsang *Department of Medical Imaging and Nuclear Medicine, First

More information

Utility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer

Utility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer Utility of F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer Ngoc Ha Le 1*, Hong Son Mai 1, Van Nguyen Le 2, Quang Bieu Bui 2 1 Department

More information

How to evaluate tumor response? Yonsei University College of Medicine Kim, Beom Kyung

How to evaluate tumor response? Yonsei University College of Medicine Kim, Beom Kyung How to evaluate tumor response? Yonsei University College of Medicine Kim, Beom Kyung End points in research for solid cancers Overall survival (OS) The most ideal one, but requires long follow-up duration

More information

Peri-Transplant Change in AFP Level: A Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation

Peri-Transplant Change in AFP Level: A Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation ORIGINAL ARTICLE Cell Therapy & Organ Transplantation http://dx.doi.org/1.3346/jkms.16.31.7.149 J Korean Med Sci 16; 31: 149-154 Peri-Transplant Change in AFP Level: A Useful Predictor of Hepatocellular

More information

A) PUBLIC HEALTH B) PRESENTATION & DIAGNOSIS

A) PUBLIC HEALTH B) PRESENTATION & DIAGNOSIS Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary), April 2017 by Dr. Jenny Ko (Medical Oncologist, Abbotsford Centre, BC Cancer

More information

Surgical resection for hepatocellular carcinoma (HCC)

Surgical resection for hepatocellular carcinoma (HCC) Surgical resection for hepatocellular carcinoma (HCC) Wojciech G Polak, MD, PhD, FEBS Department of Surgery, Division of HPB and Transplant Surgery, Erasmus MC, University Medical Center Rotterdam the

More information

Over the past 20 years, great progress has been made in the

Over the past 20 years, great progress has been made in the ORIGINAL ARTICLES Staging of Hepatocellular Carcinoma Assessment of the Japanese TNM and AJCC/UICC TNM Systems in a Cohort of 13,772 Patients in Japan Masami Minagawa, MD, PhD,* Iwao Ikai, MD, PhD,* Yutaka

More information

Taller-Than-Wide Sign of Thyroid Malignancy: Comparison Between Ultrasound and CT

Taller-Than-Wide Sign of Thyroid Malignancy: Comparison Between Ultrasound and CT Neuroradiology/Head and Neck Imaging Original Research Yoon et al. Taller-Than-Wide Sign of Thyroid Malignancy Neuroradiology/Head and Neck Imaging Original Research Soo Jeong Yoon 1 Dae Young Yoon 1,2

More information

Fracture risk in unicameral bone cyst. Is magnetic resonance imaging a better predictor than plain radiography?

Fracture risk in unicameral bone cyst. Is magnetic resonance imaging a better predictor than plain radiography? Acta Orthop. Belg., 2011, 77, 230-238 ORIGINAL STUDY Fracture risk in unicameral bone cyst. Is magnetic resonance imaging a better predictor than plain radiography? Nathalie PiREAU, Antoine DE GHELDERE,

More information

Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma

Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma Li et al. World Journal of Surgical Oncology (2015) 13:294 DOI 10.1186/s12957-015-0713-4 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Negative impact of low body mass index on liver cirrhosis

More information

Imaging of liver and pancreas

Imaging of liver and pancreas Imaging of liver and pancreas.. Disease of the liver Focal liver disease Diffusion liver disease Focal liver disease Benign Cyst Abscess Hemangioma FNH Hepatic adenoma HCC Malignant Fibrolamellar carcinoma

More information

MEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES

MEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES MEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES Although response is not the primary endpoint of this trial, subjects with measurable disease will be assessed by standard criteria. For the purposes of this

More information

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital Newcastle HPB MDM updated radiology imaging protocol recommendations Author Dr John Scott. Consultant Radiologist Freeman Hospital This document is intended as a guide to aid radiologists and clinicians

More information

Gastrointestinal Imaging Original Research

Gastrointestinal Imaging Original Research Gastrointestinal Imaging Original Research Potretzke et al. iphenotypic Primary Liver Carcinoma Gastrointestinal Imaging Original Research FOCUS ON: Theodora. Potretzke 1 enjamin R. Tan 2 Maria. Doyle

More information

Histologic characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on 4-phase multidetector CT examination

Histologic characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on 4-phase multidetector CT examination Histologic characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on 4-phase multidetector CT examination Injoong Kim Department of Medicine The Graduate School, Yonsei

More information

Actual 10-year survival following hepatectomy for hepatocellular carcinoma

Actual 10-year survival following hepatectomy for hepatocellular carcinoma DOI:10.1111/hpb.12206 HPB ORIGINAL ARTICLE Actual 10-year survival following hepatectomy for hepatocellular carcinoma Bernardo Franssen, Ghalib Jibara, Parissa Tabrizian, Myron E. Schwartz & Sasan Roayaie

More information

Anterior Spinal Artery and Artery of Adamkiewicz Detected by Using Multi-Detector Row CT

Anterior Spinal Artery and Artery of Adamkiewicz Detected by Using Multi-Detector Row CT AJNR Am J Neuroradiol 24:13 17, January 2003 Anterior Spinal Artery and Artery of Adamkiewicz Detected by Using Multi-Detector Row CT Kohsuke Kudo, Satoshi Terae, Takeshi Asano, Masaki Oka, Kenshi Kaneko,

More information

Surveillance for HCC Who, how Diagnosis of HCC Surveillance for HCC in Practice

Surveillance for HCC Who, how Diagnosis of HCC Surveillance for HCC in Practice Surveillance for Hepatocellular Carcinoma Hashem B. El-Serag, MD, MPH Dan L. Duncan Professor of Medicine Chief, Gastroenterology and Hepatology Houston VA & Baylor College of Medicine Houston, TX Outline

More information

Communicating Vein between the Left Renal Vein and Left Ascending Lumber Vein: Incidence and Significance on Abdominal CT

Communicating Vein between the Left Renal Vein and Left Ascending Lumber Vein: Incidence and Significance on Abdominal CT YAO ET AL ORIGINAL ARTICLE Radiation Medicine: Vol. 21 No. 6, 252 257 p.p., 2003 Communicating Vein between the Left Renal Vein and Left Ascending Lumber Vein: Incidence and Significance on Abdominal CT

More information

Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study

Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study Original article Annals of Gastroenterology (2013) 26, 346-352 Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study Subhankar Chakraborty

More information

Liver metastases: treatment planning. PJ Valette

Liver metastases: treatment planning. PJ Valette Liver metastases: treatment planning PJ Valette Liver metastases removal December 2010 April 2011 : after chemotherapy June 2011 : after resection of left lobe mets & portal embol. Sept 2011 : 1 year after

More information

Medicine. Infiltrative Hepatocellular Carcinoma. Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy

Medicine. Infiltrative Hepatocellular Carcinoma. Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy Medicine OBSERVATIONAL STUDY Infiltrative Hepatocellular Carcinoma Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy Xiaopeng Yan, MD, Xu Fu, MD, Min Deng, MM, Jun Chen,

More information

Objectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma

Objectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma Imaging of Hepatocellular Carcinoma and the use of LI RADS Treatment of Hepatocellular Carcinoma Aaron D. Anderson, D.O. AOCR April 2015 Objectives Show how the use of LI RADS can simplify the diagnosis

More information

Imaging Features of Sclerosed Hemangioma

Imaging Features of Sclerosed Hemangioma Sclerosed Hemangioma Abdominal Imaging Clinical Observations Deirdre J. Doyle 1 Korosh Khalili 1 Maha Guindi 2 Mostafa Atri 3 Doyle DJ, Khalili K, Guindi M, Atri M Keywords: abdominal imaging, CT, liver,

More information

Gadoxetic Acid enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases

Gadoxetic Acid enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases ORIGINAL RESEARCH GASTROINTESTINAL IMAGING Gadoxetic Acid enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases Dong Hwan Kim, MD* Sang Hyun Choi, MD, PhD*

More information